RTS Life Science, the supplier of automated sample management and pharmaceutical testing systems, has announced the formation of a new Pharmaceutical Testing Group.
Following the acquisition of a Massachusetts based life science company earlier this year, the new Pharmaceutical Testing group integrates UK developed products for inhaler and tablet testing with new US developed products for dissolution and content uniformity testing.
The newly formed Pharmaceutical Testing Group, comprises both UK and US teams working together on the now extensive range of analytical development, quality control, dose content uniformity and dissolution testing systems.
With an impressive installed base of over 30 systems, extensive experience and expertise exists on both sides of the Atlantic in the fields of tablet and inhaler testing automation.
Martin Schwalm, President of RTS Life Science LLC commented “Our new combined range of tablet and inhaler testing helps us better serve the broad needs of our pharmaceutical development and QC customers”.
Mark Fish, Director for inhalation automation at RTS commented “Our new US office and base will help us better serve and support the US market with our proven automation solutions for inhaler testing”
RTS Life Science
